Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Symptomatic Uterine Fibroids
NCT03210324Phase 4Terminated
- Sponsor
- China Resources Zizhu Pharmaceutical
- Start
- Jun 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mifepristone in Uterine Fibroids (UF), sponsored by China Resources Zizhu Pharmaceutical. Started Jun 2017; status: terminated.
02
Drugs
mifepristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03210324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210324.